Welcome to the ValueWiki Poniard Pharmaecuticals, Inc. (PARD) article! Register for free or click the "edit" link to contribute!

Poniard Pharmaecuticals, Inc. (PARD)

This summary section needs content! Click Here to begin writing.

Have a question about Poniard Pharmaecuticals, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/13/08 9:11 am	PONIARD PHARMACEUTICALS, INC. Financials (EDGAR Online Financials)
11/06/08 3:11 pm	PONIARD PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)
11/06/08 8:11 am	Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin (PR Newswire)
11/03/08 1:11 pm	PONIARD PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online)
10/30/08 3:10 pm	Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update (PR Newswire)
10/30/08 6:10 am	Q3 2008 Poniard Pharmaceuticals Earnings Release - After Market Close (CCBN)
10/28/08 7:10 am	Poniard Pharmaceuticals Announces Upcoming Conference Participation (PR Newswire)
10/23/08 7:10 am	Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30 (PR Newswire)
10/21/08 7:10 am	Poniard Pharmaceuticals' Picoplatin Named by Windhover Among Top 10 Most Promising Oncology Products (PR Newswire)
10/06/08 3:10 pm	PONIARD PHARMACEUTICALS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an (EDGAR Online)